Baird Medical Investment Holdings Limited (NASDAQ:BDMD - Get Free Report)'s share price traded down 1.7% during mid-day trading on Friday . The stock traded as low as $2.30 and last traded at $2.31. 17,999 shares changed hands during trading, a decline of 92% from the average session volume of 238,525 shares. The stock had previously closed at $2.35.
Analyst Ratings Changes
Separately, Wall Street Zen lowered Baird Medical Investment from a "hold" rating to a "sell" rating in a research report on Monday, July 14th.
View Our Latest Stock Report on Baird Medical Investment
Baird Medical Investment Price Performance
The company has a 50 day simple moving average of $2.54 and a 200 day simple moving average of $4.24.
Institutional Investors Weigh In On Baird Medical Investment
Several institutional investors have recently bought and sold shares of BDMD. Jane Street Group LLC bought a new stake in Baird Medical Investment in the 2nd quarter valued at approximately $142,000. XTX Topco Ltd bought a new stake in shares of Baird Medical Investment during the 1st quarter worth approximately $111,000. Finally, Geode Capital Management LLC raised its stake in shares of Baird Medical Investment by 59.7% during the 2nd quarter. Geode Capital Management LLC now owns 25,442 shares of the company's stock worth $93,000 after purchasing an additional 9,511 shares in the last quarter. Institutional investors own 19.78% of the company's stock.
About Baird Medical Investment
(
Get Free Report)
Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.
Further Reading
Before you consider Baird Medical Investment, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Baird Medical Investment wasn't on the list.
While Baird Medical Investment currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.